loading...
Annoying But Necessary: Navigating the Operational Challenges of Long-Acting Treatment and Prevention Strategies
Annoying But Necessary: Navigating the Operational Challenges of Long-Acting Treatment and Prevention StrategiesPresenter: Joshua P. Havens, PharmD Click to Download Slides On-Demand Webcast Podcast iasusa · Annoying But Necessary: Navigating the Challenges of LA Treatment & Prevention Strategies Text on the button
DETAIL
Challenging Cases in Long-Acting Treatment and Prevention: What Would You Do?
Challenging Cases in Long-Acting Treatment and Prevention: What Would You Do?Presenter: Raphael J. Landovitz, MD, MSc Click to Download Slides On-Demand Webcast Podcast iasusa · Challenging Cases in LA Treatment and Prevention: What Would You Do? Text on the button
DETAIL
State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIV
State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIVPresenter: Aadia I. Rana, MD Click to Download Slides On-Demand Webcast Podcast iasusa · State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIV Text on the button
DETAIL
State of the Science: What We Know about Long-Acting Injectable Agents for HIV Prevention
State of the Science: What We Know about Long-Acting Injectable Agents for HIV PreventionPresenter: Colleen Kelley, MP, MPH Click to Download Slides On-Demand Webcast Podcast iasusa · State of the Science: What We Know about Long-Acting Injectable Agents for HIV Prevention Text on the button
DETAIL
Lifetime of Leadership Award Presented to Gerald H. Friedland, MD
Recipient: Gerald H. Friedland, MD
Evolving Diabetes Care in People With HIV: Screening, Treatment, and the Rise of GLP-1 Therapies
Presenter: Ole-Petter R. Hamnvik, MB BCh BAO, MMSc
Substance Use in HIV Care: MOUD, Emerging Therapies, and PrEP in the Context of Stimulant Use
Presenter: Ellen F. Eaton, MD